Arkolith/Insider Trading/CUE

CUE Insider Trading

Cue Biopharma, Inc. · full profile →Last filing Aug 13, 2026
Net Selling · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$2.0M
3 insiders
Net Insider Flow
-$2.0M
open market, 180d
Reporting Insiders
3
11 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerOption exercise(M)14K—$0
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSell(S)3$31.13$93
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSell(S)4K$30.35$125K
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSell(S)2K$29.37$45K
Aug 13, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerOption exercise(M)14K—$0
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerOption exercise(M)18K—$0
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerSell(S)4$31.13$125
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerSell(S)6K$30.35$196K
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerSell(S)2K$29.37$70K
Aug 13, 2026Ray SumitaChief Legal Compliance OfficerOption exercise(M)18K—$0
Aug 13, 2026Lin Shao-LeeChief Executive Officer, DirectorSell(S)10K$29.48$308K
Aug 13, 2026Lin Shao-LeeChief Executive Officer, DirectorSell(S)2K$28.11$67K
Aug 13, 2026Lin Shao-LeeChief Executive Officer, DirectorSell(S)5K$27.19$147K
Aug 12, 2026Lin Shao-LeeChief Executive Officer, DirectorOption exercise(M)109K—$0
Aug 12, 2026Lin Shao-LeeChief Executive Officer, DirectorSell(S)6K$27.75$160K
Aug 12, 2026Lin Shao-LeeChief Executive Officer, DirectorSell(S)34K$26.99$924K
Aug 12, 2026Lin Shao-LeeChief Executive Officer, DirectorOption exercise(M)109K—$0
Jul 30, 2026Ahlers James MChief Financial OfficerGrant(A)51K—$0
Jul 30, 2026Ahlers James MChief Financial OfficerGrant(A)26K—$0
Jul 13, 2026Borie Dominique ChristianChief Medical OfficerGrant(A)32K—$0
Jul 13, 2026Borie Dominique ChristianChief Medical OfficerGrant(A)63K—$0
Jul 9, 2026Garzone PamelaDirectorGrant(A)19K—$0
Jul 9, 2026Sarraf PashaDirectorGrant(A)18K—$0
Jul 9, 2026Camardo Daniel A.DirectorGrant(A)22K—$0
Jul 9, 2026Meehan Viola MongDirectorGrant(A)22K—$0
Jul 9, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerGrant(A)41K—$0
Jul 9, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerGrant(A)41K—$0
Jul 9, 2026Ray SumitaChief Legal Compliance OfficerGrant(A)55K—$0
Jul 9, 2026Ray SumitaChief Legal Compliance OfficerGrant(A)55K—$0
Jul 9, 2026Lin Shao-LeeChief Executive Officer, DirectorGrant(A)328K—$0
Jul 9, 2026Lin Shao-LeeChief Executive Officer, DirectorGrant(A)328K—$0
Jun 1, 2026Lin Shao-LeeChief Executive Officer, DirectorGrant(A)45K——
Jun 1, 2026Lin Shao-LeeChief Executive Officer, DirectorGrant(A)91K$11.00$1000K
Jun 1, 2026Lin Shao-LeeChief Executive Officer, DirectorBuy(P)91K$11.00$1000K
Jun 1, 2026Lin Shao-LeeChief Executive Officer, DirectorBuy(P)45K——
May 30, 2026Meehan Viola MongDirectorGrant(A)2K—$0
May 30, 2026Camardo Daniel A.DirectorGrant(A)2K—$0
May 3, 2026Lin Shao-LeeCHIEF EXECUTIVE OFFICER, DirectorGrant(A)328K—$0
May 3, 2026Lin Shao-LeeCHIEF EXECUTIVE OFFICER, DirectorGrant(A)655K—$0
Apr 9, 2026Baker Daniel G.CHIEF DEVELOPMENT OFFICERGrant(A)100K—$0
Apr 9, 2026Warren LucindaCHIEF BUSINESS OFFICERGrant(A)250K—$0
Apr 9, 2026Sandercock ColinSVP, GENERAL COUNSELGrant(A)200K—$0
Jan 2, 2026Sarraf PashaDirectorGrant(A)24K—$0
Jan 2, 2026Verheyen PatrickDirectorGrant(A)24K—$0
Jan 2, 2026Garzone PamelaDirectorGrant(A)24K—$0
Jan 2, 2026Morich FrankDirectorGrant(A)24K—$0
Jan 2, 2026Broadfoot Jill MarieDirectorGrant(A)24K—$0
Jan 2, 2026Kiener Peter ADirectorGrant(A)24K—$0
Dec 30, 2025Sarraf PashaDirectorBuy(P)77K$0.30$23K
Dec 30, 2025Sarraf PashaDirectorBuy(P)87K$0.32$28K
Dec 30, 2025Sarraf PashaDirectorBuy(P)77K$0.30$23K
Dec 30, 2025Sarraf PashaDirectorBuy(P)4K$0.31$1K
Dec 30, 2025Sarraf PashaDirectorBuy(P)78K$0.31$24K
Dec 3, 2025Sandercock ColinSVP, GENERAL COUNSELGrant(A)70K—$0
Sep 29, 2025Azam UsmanCHIEF EXECUTIVE OFFICER, DirectorGrant(A)1.9M—$0
Sep 29, 2025Baker Daniel G.CHIEF DEVELOPMENT OFFICERGrant(A)50K—$0
Sep 29, 2025Warren LucindaCHIEF BUSINESS OFFICERGrant(A)125K—$0
Sep 26, 2025Sandercock ColinSVP, GENERAL COUNSELGrant(A)30K—$0
Jun 4, 2025Broadfoot Jill MarieDirectorGrant(A)49K—$0
Mar 21, 2025Levisetti MatteoChief Medical OfficerGrant(A)250K—$0
Mar 21, 2025Warren LucindaCHIEF BUSINESS OFFICERGrant(A)250K—$0
Mar 21, 2025Sandercock ColinSVP, GENERAL COUNSELGrant(A)200K—$0
Mar 21, 2025Baker Daniel G.CHIEF DEVELOPMENT OFFICERGrant(A)100K—$0
Mar 21, 2025Passeri Daniel RCHIEF EXECUTIVE OFFICER, DirectorGrant(A)450K—$0
Mar 21, 2025Millar Kerri-AnnCHIEF FINANCIAL OFFICERGrant(A)200K—$0
Mar 10, 2025Sarraf PashaDirectorGrant(A)49K—$0
Jan 2, 2025Garzone PamelaDirectorGrant(A)24K—$0
Jan 2, 2025Verheyen PatrickDirectorGrant(A)24K—$0
Jan 2, 2025Kiener Peter ADirectorGrant(A)24K—$0
Jan 2, 2025Driscoll Frederick WDirectorGrant(A)24K—$0
Jan 2, 2025Morich FrankDirectorGrant(A)24K—$0
Dec 16, 2024Passeri Daniel RCHIEF EXECUTIVE OFFICER, DirectorBuy(P)30K$1.03$31K
Nov 25, 2024Baker Daniel G.CHIEF DEVELOPMENT OFFICERGrant(A)200K—$0
Sep 3, 2024Warren LucindaCHIEF BUSINESS OFFICERGrant(A)350K—$0
Jun 5, 2024Millar Kerri-AnnCHIEF FINANCIAL OFFICERGrant(A)60K—$0
Jun 5, 2024Sandercock ColinSVP, GENERAL COUNSELGrant(A)60K—$0
Jun 5, 2024Fox Michael JDirectorGrant(A)49K—$0
Jun 5, 2024Suri AnishPRESIDENT AND CSOGrant(A)150K—$0
Jun 5, 2024Levisetti MatteoChief Medical OfficerGrant(A)125K—$0
Mar 6, 2024Levisetti MatteoChief Medical OfficerGrant(A)260K—$0
Mar 6, 2024Passeri Daniel RCHIEF EXECUTIVE OFFICER, DirectorGrant(A)400K—$0
Mar 6, 2024Suri AnishPRESIDENT AND CSOGrant(A)300K—$0
Mar 6, 2024Millar Kerri-AnnCHIEF FINANCIAL OFFICERGrant(A)250K—$0
Mar 6, 2024Sandercock ColinSVP, GENERAL COUNSELGrant(A)175K—$0
Feb 20, 2024Levisetti MatteoChief Medical OfficerGrant(A)25K—$0
Jan 2, 2024Morich FrankDirectorGrant(A)24K—$0
Jan 2, 2024Verheyen PatrickDirectorGrant(A)24K—$0
Jan 2, 2024Driscoll Frederick WDirectorGrant(A)24K—$0
Jan 2, 2024Kiener Peter ADirectorGrant(A)24K—$0
Jan 2, 2024Garzone PamelaDirectorGrant(A)24K—$0
Aug 25, 2023Suri AnishPRESIDENT AND CSOBuy(P)4K$2.76$11K
Aug 14, 2023Passeri Daniel RCHIEF EXECUTIVE OFFICER, DirectorBuy(P)3K$2.86$9K
Jul 21, 2023Suri AnishPRESIDENT AND CSOGrant(A)124K—$0
Jul 21, 2023Sandercock ColinSVP, GENERAL COUNSELGrant(A)75K—$0
Jul 21, 2023Passeri Daniel RCHIEF EXECUTIVE OFFICER, DirectorGrant(A)450K—$0
Jul 21, 2023Millar Kerri-AnnCHIEF FINANCIAL OFFICERGrant(A)113K—$0
Jul 21, 2023Levisetti MatteoChief Medical OfficerGrant(A)83K—$0
Apr 19, 2023Garzone PamelaDirectorGrant(A)40K—$0
Apr 11, 2023Verheyen PatrickDirectorGrant(A)40K—$0
Mar 23, 2023Kiener Peter ADirectorOption exercise(M)10K$2.86$28K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Issuer: Cue Biopharma, Inc., SEC CIK 0001645460. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under CUE and shows every filing by that issuer.

Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for CUE